v3.26.1
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Statement of Financial Position [Abstract]    
Available for sale securities, amortized cost $ 3,775,708 $ 3,793,777
Allowance for expected credit losses 4,299 4,306
Trading securities, cost 13,487 14,202
Equity investments at fair value, cost 121,742 121,766
Other investments, portion carried at fair value 0 1,215
Premium receivable, allowance for credit loss $ 7,951 $ 7,829
Common shares, par value (in usd per share) $ 0.01 $ 0.01
Common shares, shares authorized (in shares) 100,000,000 100,000,000
Common shares, shares issued (in shares) 64,214,694 64,020,611
Deferred tax expense (benefit) on accumulated other comprehensive income (loss) $ (26,942) $ (21,905)
Treasury shares (in shares) 12,606,968 12,606,968